| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1831* | 2021 |
| The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages M Daigneault, JA Preston, HM Marriott, MKB Whyte, DH Dockrell PloS one 5 (1), e8668, 2010 | 1343 | 2010 |
| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 576 | 2008 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 436* | 2021 |
| Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo L Allen, DH Dockrell, T Pattery, DG Lee, P Cornelis, PG Hellewell, ... The Journal of Immunology 174 (6), 3643-3649, 2005 | 332 | 2005 |
| Toll-like receptors in health and disease: complex questions remain I Sabroe, RC Read, MKB Whyte, DH Dockrell, SN Vogel, SK Dower The journal of immunology 171 (4), 1630-1635, 2003 | 321 | 2003 |
| Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection DH Dockrell, HM Marriott, LR Prince, VC Ridger, PG Ince, PG Hellewell, ... The Journal of Immunology 171 (10), 5380-5388, 2003 | 302 | 2003 |
| Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants RH Lohr, BJ Boland, WW Douglas, DH Dockrell, TV Colby, SJ Swensen, ... Archives of internal medicine 157 (12), 1323-1329, 1997 | 302 | 1997 |
| Macrophage-dependent Apoptosis of CD4+ T Lymphocytes from HIV-infected Individuals Is Mediated by FasL and Tumor Necrosis Factor AD Badley, D Dockrell, M Simpson, R Schut, DH Lynch, P Leibson, ... The Journal of experimental medicine 185 (1), 55-64, 1997 | 284 | 1997 |
| Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV … Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1145-1155, 2008 | 259 | 2008 |
| Acceleration of human neutrophil apoptosis by TRAIL SA Renshaw, JS Parmar, V Singleton, SJ Rowe, DH Dockrell, SK Dower, ... The Journal of Immunology 170 (2), 1027-1033, 2003 | 246 | 2003 |
| Imiquimod and resiquimod as novel immunomodulators DH Dockrell, GR Kinghorn Journal of Antimicrobial Chemotherapy 48 (6), 751-755, 2001 | 239 | 2001 |
| Pneumolysin: a double-edged sword during the host-pathogen interaction HM Marriott, TJ Mitchell, DH Dockrell Current molecular medicine 8 (6), 497-509, 2008 | 237 | 2008 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 231 | 2022 |
| Human β-Herpesvirus Interactions in Solid Organ Transplant Recipients JC Mendez, DH Dockrell, MJ Espy, TF Smith, JA Wilson, WS Harmsen, ... The Journal of infectious diseases 183 (2), 179-184, 2001 | 217 | 2001 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 214 | 2022 |
| Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients JM Sarmiento, DH Dockrell, TR Schwab, SR Munn, CV Paya Clinical transplantation 14 (2), 136-138, 2000 | 213 | 2000 |
| Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority … JM Molina, K Squires, PE Sax, P Cahn, J Lombaard, E DeJesus, MT Lai, ... The lancet HIV 5 (5), e211-e220, 2018 | 209 | 2018 |
| Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice SR Walmsley, ER Chilvers, AA Thompson, K Vaughan, HM Marriott, ... The Journal of clinical investigation 121 (3), 1053-1063, 2011 | 203 | 2011 |
| Human herpesvirus 6: molecular biology and clinical features DH Dockrell Journal of medical microbiology 52 (1), 5-18, 2003 | 173 | 2003 |
